Add Yahoo as a preferred source to see more of our stories on Google. CystoSmart aims to help clinicians improve diagnostic accuracy during cystoscopy procedures. Credit: SOMKID THONGDEE / ...

SINGAPORE and LONDON and NEW YORK, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp (“ISC”), specializing in state-of-the-art image enhancement and precision AI software solutions for urology ...

You chose selected. Each dot here represents a single video about selected. While you’re on the app, TikTok tracks how you interact with videos. It monitors your watch time, the videos you like, the ...

I treat patients in a hospital. You’re a doctor who works for an insurance company. Are we really peers? Tessa Adzemovic is a physician at Brigham and Women’s Hospital. My phone rings and an ...

Personalized algorithms may quietly sabotage how people learn, nudging them into narrow tunnels of information even when they start with zero prior knowledge. In the study, participants using ...

We’re racing towards a future in which devices will be able to read our thoughts. You see signs of it everywhere, from brain-computer interfaces to algorithms that detect emotions from facial scans.

SCAN Health Plan is teaming up with big-box retailer Costco to offer members notable cost savings on medications, key vaccinations and other over-the-counter essentials. Costco will become a preferred ...

Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based detection of molecular residual disease may identify patients at high risk for ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

The NFL Hall of Famer also discuss why he decided to share the news publicly. Deion Sanders is opening up about a fight that changed his life. The NFL Hall of Famer and Colorado Buffaloes head coach ...

The FDA has signed off on Johnson & Johnson’s highly anticipated bladder cancer drug Inlexzo, marking an advance in the ability to care for patients who otherwise face bladder removal and limited ...

Inlexzo is approved for BCG-unresponsive NMIBC with CIS, offering a new treatment option for patients with limited alternatives. The SunRISe-1 trial showed an 82% complete response rate, with 51% ...